Vital Chemtech FY26 profit falls 74.1% to ₹1 crore
Vital Chemtech Limited announced its audited financial results for Q4FY26 and FY26, reporting a 74.1% YoY decline in PAT to ₹1.0 crore for the full year. Revenue for FY26 stood at ₹126.4 crore, a 5.6% decrease from the previous year, while Q4 revenue remained flat at ₹35.1 crore. The company improved Q4 EBITDA by 39.7% to ₹4.0 crore but noted that profitability was impacted by investments in subsidiaries Vital Synthesis Limited and Vital Alkoxides Private Limited.
*this image is generated using AI for illustrative purposes only.
Vital Chemtech Limited reported a 74.1% year-on-year decline in profit after tax (PAT) to ₹1.0 crore for the financial year ended March 31, 2026 (FY26), impacted by investments in its subsidiaries. Revenue from operations for FY26 decreased by 5.6% to ₹126.4 crore, compared to ₹133.9 crore in FY25. The company disclosed its audited standalone and consolidated financial results for Q4FY26 and FY26 on June 1, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
For the quarter ended March 31, 2026 (Q4FY26), revenue remained stable at ₹35.1 crore. EBITDA for the quarter rose 39.7% to ₹4.0 crore, with margins expanding by 320 basis points to 11.3%. However, Q4 PAT declined by 28.2% to ₹0.8 crore, with margins contracting by 95 basis points to 2.4%. The statutory auditors, M/s Abhishek Kumar & Associates, issued an unmodified opinion on the financial statements.
Financial Performance Summary
| ₹ crores unless otherwise mentioned | Q4 FY26 | Q4 FY25 | YoY change (%) | FY26 | FY25 | YoY change (%) |
|---|---|---|---|---|---|---|
| Revenue from operations | 35.1 | 35.1 | 0.2% | 126.4 | 133.9 | -5.6% |
| EBITDA | 4.0 | 2.8 | 39.7% | 10.0 | 10.6 | -5.6% |
| EBITDA Margin | 11.3% | 8.1% | 320 bps | 7.9% | 7.9% | 0 bps |
| Profit after tax | 0.8 | 1.2 | -28.2% | 1.0 | 4.0 | -74.1% |
| PAT Margin | 2.4% | 3.3% | -95 bps | 0.8% | 3.0% | -215 bps |
| EPS (₹) | 0.4 | 0.5 | -26.5% | 0.4 | 1.7 | -74.1% |
Operational Highlights
The decline in profitability was primarily attributable to investments made in two subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited. Vital Synthesis Limited commenced commercial operations in Q3 FY26 and is witnessing a gradual scale-up in customer acceptance. Vital Alkoxides Private Limited delivered strong business momentum during FY26, achieving approximately 63% YoY revenue growth.
Vipul Bhatt, Chairman and Managing Director, stated that the company focused on strengthening its business foundation through strategic investments and operational improvements. He noted that while investments in subsidiaries impacted short-term profitability, they are expected to strengthen the group's growth platform and diversification strategy. The company operates a fully automated manufacturing complex at Dahej, Gujarat, with a cumulative installed capacity of 33,192 MT.
Historical Stock Returns for Vital Chemtech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.99% | -7.26% | -13.81% | -5.51% | -24.68% | -68.14% |
When does Vital Chemtech expect the investments in subsidiaries to translate into positive earnings?
What is the projected revenue contribution from Vital Synthesis Limited as customer acceptance scales up?
Will the company continue to prioritize expansion over profitability in the coming fiscal year?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
